Literature DB >> 21503185

A Case report: Herpes zooster IRIS in pregnancy.

Christine Katusiime1, P Ocama, A Kambugu.   

Abstract

Pregnant women are increasingly being initiated on antiretroviral therapy either as part of prevention of mother to child transmission of HIV or as purely highly active antiretroviral therapy.In this case report, we describe a 26 year old woman who was 28 weeks pregnant and who presented after 4 weeks of initiation of antiretroviral therapy with a herpes zoster eruption and how the case was managed at the Infectious Diseases Institute, Kampala, Uganda.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21503185      PMCID: PMC3074397     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  8 in total

Review 1.  Immunological tolerance of the human fetus.

Authors:  G Gaunt; K Ramin
Journal:  Am J Perinatol       Date:  2001-09       Impact factor: 1.862

Review 2.  Immunology of pregnancy. Implications for the mother.

Authors:  Jill A Poole; Henry N Claman
Journal:  Clin Rev Allergy Immunol       Date:  2004-06       Impact factor: 8.667

3.  TH1/TH2,3 imbalance due to cytokine-producing NK, gammadelta T and NK-gammadelta T cells in murine pregnancy decidua in success or failure of pregnancy.

Authors:  D A Clark; K Croitoru
Journal:  Am J Reprod Immunol       Date:  2001-05       Impact factor: 3.886

4.  Endometrial Th2 cytokine expression throughout the menstrual cycle and early pregnancy.

Authors:  J S Krasnow; D J Tollerud; G Naus; J A DeLoia
Journal:  Hum Reprod       Date:  1996-08       Impact factor: 6.918

5.  Humoral and cell-mediated immune responses to herpesvirus antigens during pregnancy--a longitudinal study.

Authors:  A Kumar; D L Madden; G A Nankervis
Journal:  J Clin Immunol       Date:  1984-01       Impact factor: 8.317

6.  Th2/Th3 cytokine genotypes are associated with pregnancy loss.

Authors:  Paul A Costeas; Anita Koumouli; Alina Giantsiou-Kyriakou; Andri Papaloizou; Laura Koumas
Journal:  Hum Immunol       Date:  2004-02       Impact factor: 2.850

7.  Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.

Authors:  I Ratnam; C Chiu; N-B Kandala; P J Easterbrook
Journal:  Clin Infect Dis       Date:  2005-12-28       Impact factor: 9.079

Review 8.  The damage-response framework of microbial pathogenesis.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Nat Rev Microbiol       Date:  2003-10       Impact factor: 60.633

  8 in total
  1 in total

1.  Central nervous system immune reconstitution inflammatory syndrome.

Authors:  Nathan Bahr; David R Boulware; Suzaan Marais; James Scriven; Robert J Wilkinson; Graeme Meintjes
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.